INSIGHTS ON DRUG DEVELOPMENT
-
Your AKTA Oligosynt™ System : It's More Than A Machine
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
Advancing 3D Cell Culture Models For Clinical Relevance
Concerns about in vitro relevance and animal study limits have advanced cell culture tech. Explore how Organ-Chips offer a refined approach to studying human physiology.
-
3 Key Considerations In Gene Therapy Manufacturing
Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
API Solubility And Dissolution Enhancement Via Formulation
Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.
-
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease10/8/2024
Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
Delving Into Gene Expression Data Analysis And Experimental Reproducibility3/5/2026
Scientific reproducibility is essential for credible research. Learn to navigate standardized frameworks, refine normalization techniques, and ensure your data remains transparent and verifiable.
-
Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load8/13/2024
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
-
ADC Tech Talks Contract Manufacturing12/9/2024
Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.
-
Nasal Delivery: Strategies For Success3/2/2026
A strengthened partnership enhances manufacturing for an ultra‑rare disease therapy, leveraging advanced containment upgrades to improve safety, reliability, capacity, and maintain global patient access.
DRUG DEVELOPMENT SOLUTIONS
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Decode 3D biology in real time*
The THUNDER Imager Model Organism allows fast and easy 3D exploration of whole organisms for developmental or molecular biology research. Thanks to THUNDER Live, your images reveal the finest structural details already in the live image. No hassle with out-of-focus blur while maintaining the capabilities and ease-of-use typical for Leica stereo microscopes.
A THUNDER Imager Model Organism is the optimal instrument for studying, e.g., Drosophila, C. elegans, zebrafish, plants, and mice. One device for screening, positioning, and imaging your specimen. Simplify your workflow and study model organisms from a large overview to the highest detail.
-
Discover how collaboration and reliability drive meaningful impact across the healthcare and life sciences industries by empowering innovation from lab to clinic.
-
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.